CUBIST PHARMACEUTICALS INC - NOTE 2.500%11/0

CUSIP: 229678AD9

Q4 2014 13F Holders as of 31 Dec 2014

Type / Class
Debt / NOTE 2.500%11/0
Market price (% of par)
346.44%
Total 13F principal
$214,574,000
Principal change
-$1,046,468
Total reported market value
$743,896,179
Number of holders
26
Value change
+$26,045,610
Number of buys
11
Number of sells
20

Quarterly Holders Quick Answers

What is CUSIP 229678AD9?
CUSIP 229678AD9 identifies 229678AD9 - CUBIST PHARMACEUTICALS INC - NOTE 2.500%11/0 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CUBIST PHARMACEUTICALS INC - NOTE 2.500%11/0 as of Q4 2014

As of 31 Dec 2014, CUBIST PHARMACEUTICALS INC - NOTE 2.500%11/0 was held by 26 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $214,574,000 in principal (par value) of the bond. The largest 10 bondholders included WOLVERINE ASSET MANAGEMENT LLC, Polar Securities Inc., BlackRock Advisors LLC, HIGHBRIDGE CAPITAL MANAGEMENT LLC, CAMDEN ASSET MANAGEMENT L P /CA, Whitebox Advisors LLC, BNP PARIBAS ARBITRAGE, SA, EQUITEC SPECIALISTS, LLC, BlackRock Group LTD, and PIPER JAFFRAY & CO.. This page lists 26 institutional bondholders reporting positions for the Q4 2014 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.